Cereno Scientific brings forward the publication of the Annual Report
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, has resolved to bring forward the publication of the Annual Report for the financial year 2023 to 26 March 2024Previously communicated was that the publication of the Annual Report for the financial year 2023 would take place during week 16, 2024, but the publication is now brought forward to 26 March 2024. The reason for the bringing forward the publication is that the Board of Directors has resolved to bring forward the Annual General Meeting to 16 April